Streetbeat News

Regulatory

BPMC

RHHBY

Genentech, a member of the Roche Group, has voluntarily withdrawn the U.S. indication of Gavreto, a drug developed in collaboration with Blueprint Medicines. The decision is not due to new safety/efficacy data for Gavreto or product safety/quality issue.

Portfolio Pulse from Charles Gross

June 30, 2023 | 10:26 am

GNFT

IPSEY

Ipsen and Genfit have announced topline data from the pivotal ELATIVE Phase 3 trial of Elafibrano for Primary Biliary Cholangitis. The trial met its primary composite endpoint, with 51% of patients achieving cholestasis response compared with 4% on placebo.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 10:18 am

ADBE

EWU

The UK's Competition and Markets Authority (CMA) has announced that it will proceed to a Phase 2 review of the Adobe/Figma deal, citing concerns that the deal could reduce innovation.

Portfolio Pulse from Charles Gross

June 30, 2023 | 10:02 am

RCEL

Avita Medical has submitted a premarket approval supplement to the FDA for RECELL GO, following the original PMA of its RECELL Autologous Cell Harvesting Device and subsequent PMA supplements.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 8:23 am

RNLX

Renalytix has received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 8:19 am

RNLX

The FDA has granted De Novo marketing authorization for Renalytix's KidneyIntelX.dkd prognostic test. The test is designed to assess the risk of progressive kidney function decline in adults with diabetes and early-stage kidney disease.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 8:16 am

BTCY

NKE

NKLA

SGH

STZ

Constellation Brands, Inc. (STZ) is expected to report quarterly earnings at $2.83 per share on revenue of $2.47 billion. Nike, Inc. (NKE) reported downbeat earnings for its fourth quarter, while sales topped estimates. SMART Global Holdings, Inc. (SGH) reported better-than-expected results for its third quarter. Nikola Corp (NKLA) has regained compliance with Nasdaq listing rules pertaining to minimum stock price. Analysts expect Biotricity, Inc. (BTCY) to post a quarterly earnings at 9 cents per share on revenue of $2.6 million.

Portfolio Pulse from Lisa Levin

June 30, 2023 | 8:13 am

GOOG

GOOGL

META

Google and Meta Platforms have decided to remove links to Canadian news sites following the Canadian Parliament’s passing of the Online News Act law that requires online platforms to pay news outlets for sharing their stories. Google plans to remove links to Canadian news from Google Search, Google News, and other products once the law goes into effect. Last week, Meta also affirmed its commitment to block news content on Facebook and Instagram in Canada.

Portfolio Pulse from Ananya Gairola

June 30, 2023 | 4:07 am

BTI

CRON

OGI

PYYX

XLY

The article discusses the potential of the cannabis industry as a source of tax revenue for the U.S. government, comparing it to the tobacco industry. It highlights that cannabis tax revenue has surpassed tobacco tax revenue in states like Colorado and Washington. The article also mentions the need for tax reform to unlock the full potential of the cannabis economy. Major tobacco players such as Philip Morris International, Altria Group, Imperial Brands, and British American Tobacco are exploring opportunities in the cannabis market.

Portfolio Pulse from Nicolás Jose Rodriguez

June 30, 2023 | 3:21 am

NKLA

Nikola Corp has regained compliance with Nasdaq listing rules pertaining to minimum stock price. The company received a written notice from Nasdaq stating that from June 14 to 28, the closing bid price of Nikola common stock was $1/share or greater. Nasdaq had issued a delisting notice to Nikola last month due to its failure to maintain a minimum bid price of $1/share.

Portfolio Pulse from Anan Ashraf

June 30, 2023 | 3:15 am